AGN News 165.65 04/24/2014 04:51:29 Allergan Inc (AGN)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Allergan Inc (AGN) 165.65 $AGN

Jim Cramer's 'Mad Money' Recap: The Market's New Reality
at The Street - Wed Apr 23, 7:20PM CDT
Investors are focusing on the positive instead of the negative, Cramer says.

Encouraging Results from Pfizer's Xeljanz - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 23, 5:20PM CDT
Pfizer Inc. (PFE) announced encouraging top-line results from two pivotal phase III studies from the OPT Program on Xeljanz.

Fitch Places Allergan's Ratings on Negative Watch
Business Wire - Wed Apr 23, 2:32PM CDT
Fitch Ratings has placed the ratings for Allergan Inc. (Allergan), including the 'A+' Issuer Default Rating (IDR), on Rating Watch Negative. The rating action stems from Valeant Pharmaceuticals International Inc.'s (Valeant) unsolicited offer to acquire Allergan for approximately $45.6 billion. The rating action applies to $2.1 billion of outstanding Allergan debt. A complete list of ratings is provided at the end of this release.

Can Allergan Find an Alternative To Valeant?
Stephen D., Simpson,, The Motley Fool - Motley Fool - Wed Apr 23, 1:30PM CDT
No one will accuse Valeant CEO Mike Pearson of lacking boldness. He has laid out a strategy for turning Valeant into one of the largest pharmaceutical/med-tech companies in the world and has proven more than willing to turn to bold...

Stock Market News for April 23, 2014 - Market News
Zacks Equity Research - Zacks Investment Research - Wed Apr 23, 9:06AM CDT
Benchmarks ended higher on Tuesday boosted by better-than-expected corporate results

Critical Alerts For Allergan, SunEdison, Valeant Pharmaceuticals, Shire PLC, and Paychex Released By InvestorsObserver
PR Newswire - Wed Apr 23, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for AGN, SUNE, VRX, SHPG, and PAYX.

Stock Price Movements, Collaborations, Earnings Releases, Upcoming Earnings and Conference Call Schedules, and Legal Updates - Analyst Notes on Allergan, Aetna, Abbott, Amgen and Medtronic
PR Newswire - Wed Apr 23, 8:30AM CDT
Today, Analysts Review released its analysts' notes regarding Allergan Inc. (NYSE: AGN), Aetna Inc. (NYSE: AET), Abbott Laboratories (NYSE: ABT), Amgen Inc. (NASDAQ: AMGN) and Medtronic Inc. (NYSE: MDT). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/1477-100free.

Allergan, Inc.: Another Billion-Dollar Buyout Target
Max Macaluso and Michael Douglass, The Motley Fool - Motley Fool - Wed Apr 23, 8:15AM CDT
Earlier this week, investors following the pharmaceutical industry may have been surprised to hear that Pfizer was interested in acquiring AstraZeneca . However, the billion-dollar buyout news didn't stop there. Yesterday, shares of Allergan ,...

Why Valeant International Inc. Is Acquiring Botox and Juvederm Maker Allergan
Beth Nichols, The Motley Fool - Motley Fool - Wed Apr 23, 7:50AM CDT
Valeant Pharmaceuticals  announced yesterday that it plans to acquire Allergan with the help of investor Bill Ackerman. Should the plan succeed, the acquisition would create a dermatology and ophthalmology giant and bring a number of the leading...

Allergan Inc. (AGN) in Focus: Stock Rallies 15.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Apr 23, 7:44AM CDT
Allergan Inc. was a big mover last session, as the company saw its shares surge over 15.0% on the day.

How Will Allergan (AGN) Stock Be Affected By Poison Pill Stance Against Valeant (VRX), Ackman?
at The Street - Wed Apr 23, 7:22AM CDT
Shares of Allergan (AGN) are slightly higher in pre-market trade after the health care company adopted a poison pill defense against the unsolicited $46 billion bid takeover from Valeant Pharmaceuticals (VRX) and activist investor Bill Ackman.

Downgrade Alert for Allergan (AGN)
Comtex SmarTrend(R) - Wed Apr 23, 6:57AM CDT
Allergan (AMEX:AGN) was downgraded from Buy to Hold at Argus Research today. The stock closed yesterday at $163.65 on volume of 32.4 million shares, above average daily volume of 3.4 million. In the past 52 weeks, shares of Allergan have traded between a low of $81.33 and a high of $165.45 and closed yesterday at $163.65, which is 101% above that low price. Over the past week, the 200-day moving average (MA) has gone up 0.7% while the 50-day MA has advanced 1.1%.

Wednesday's Artery-Clogging Fast-Food Earnings Reports, and Potential Botox Merger
Jack Kramer and Nick Martell, The Motley Fool - Motley Fool - Wed Apr 23, 5:00AM CDT
Get ready to pack an artery with some corporate earnings from America's publicly traded fast-food all-stars. The Dow rose 65 points Tuesday as investors continue to eat up stocks like they're mid McNugget-binge. 1. McDonald's first-quarter...

MarketResearchReports.Com: Migraine - United States Drug Forecast and Market Analysis to 2023, New Report Launched
M2 - Wed Apr 23, 3:57AM CDT
The migraine market is saturated with generic drugs, and the remaining branded products already on the market are expected to lose exclusivity during the next few years, with the exception of Botox for chronic migraine, which is expected to maintain its leading position in terms of sales. However, reformulations of mature products as well as new classes of therapies are anticipated to launch during the forecast period and these will contribute to the market growth. By 2023, the migraine market will grow to $3.7 billion at a compound annual growth rate (CAGR) of 3.6%, with the US continuing to dominate the market as a result of higher drug prices and a large migraine population. Some of the new treatments are expected to target the key unmet needs but opportunities will remain for further treatment choices especially drugs that will offer an improved safety and side-effects profile.

ALLERGAN INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Allergan, Inc.
PR Newswire - Tue Apr 22, 9:24PM CDT
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF" are investigating the proposed sale of Allergan, Inc. ("Allergan" or the "Company" (NYSE: AGN) to Valeant Pharmaceuticals International, Inc. ("Valeant" (NYSE: VRX). Under the terms of the proposed transaction, shareholders of Allergan would receive only $48.30 in cash and 0.83 shares of Valeant common stock for each share of Allergan common stock that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.

Valeant, Ackman make $45.6B Allergan bid
AP - Tue Apr 22, 7:43PM CDT
NEW YORK (AP) — Valeant Pharmaceuticals and activist investor Bill Ackman have unveiled details of their offer to buy Botox maker Allergan, proposing a cash-and-stock deal that could be worth about $45.6 billion.

Allergan Adopts One-Year Stockholder Rights Plan
Business Wire - Tue Apr 22, 7:25PM CDT
Allergan, Inc. (NYSE: AGN) ("Allergan" or the "Company" today announced that its Board of Directors (the "Board" has unanimously adopted a one-year stockholder rights plan (the "Plan" effective April 22, 2014 and declared a dividend distribution of one preferred share purchase right on each outstanding share of the Company's common stock.

Jim Cramer's 'Mad Money' Recap: Opportunities Are Still Out There
at The Street - Tue Apr 22, 7:13PM CDT
There have been many sectors that have not been participating in the market's rally -- until today, Cramer says.

Drugmakers Prod European Stocks To Post-Easter Rally
at Investor's Business Daily - Tue Apr 22, 5:36PM CDT
European exchanges were high scorers on the world map Tuesday, as investors returned with vigor from the four-day holiday. Germany's Frankfurt Exchange led the pack, with the DAX index vaulting 2% higher. In Italy, Milano's FTSE MIB punched up 1.5%....

NYSE stocks posting largest volume increases
AP - Tue Apr 22, 5:02PM CDT
NEW YORK (AP) — A look at the 10 biggest volume gainers on New York Stock Exchange at the close of trading:
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Alphabet Lawsuit Puts Gemini Delays Under a Microscope

Updated Category News Views 99

July’s twin punches to Alphabet shares were not the sort of wobble investors can casually shrug off. First came a report on July 16 that Google was months behind on Gemini 3.5 Pro, its flagship AI model, after disappointing results from updated training data. Then came the harder financial reality a week later: a much larger 2026 capital-spending plan, negative...

Continue Reading
Kuaishou’s AI Push Meets a Brutal Earnings Reality

Updated Category News Views 133

Kuaishou just put a very expensive wrinkle in its AI story. The third-quarter figures are not a minor wobble: revenue dropped 11.1% year over year to RMB31.6 billion, gross margin slid from 54.7% to 48.2%, and the company swung from a RMB4.5 billion profit to a RMB959 million loss. For holders of 01024, that is the sort of earnings release that demands less daydreaming...

Continue Reading
Freedom Debt Relief Earns Service Recognition in 2026

Updated Category News Views 161

A Service Badge Carries Weight in a Rough Business Debt settlement is not a business where a pleasant phone voice alone gets the job done. People arrive carrying unsecured balances, anxiety, and usually a fair amount of distrust. That is why CNBC Select naming Freedom Debt Relief its “Best for Customer Service” is more meaningful than the usual chest-thumping...

Continue Reading
PenFed’s Toys for Tots Drive Targets Holiday Gift Gaps

Updated Category News Views 34

A missing present under a tree is not a statistic anybody ought to glide past. PenFed Credit Union has opened its annual Toys for Tots collection across Washington-region branches, taking new, unwrapped toys through December 8 at 1:00 p.m. ET. The useful detail, and frankly the one worth remembering when people default to buying the easiest shiny thing on a shelf, is...

Continue Reading
Blast Doubles Athabasca Ground, but Drills Still Matter

Updated Category News Views 75

More ground in Athabasca can wake up a uranium junior fast, and Blast Resources has certainly grabbed investors’ attention with this one. The company has optioned eight additional uranium claims beside its Wales Lake property in northern Saskatchewan, taking its regional footprint from 12,150 hectares across 16 claims to 30,732 hectares across 24 claims. That is more...

Continue Reading
Rafay's Third Fast 500 Nod Tracks AI Cloud Buildout

Updated Category News Views 51

GPU warehouses are easy to admire and brutally hard to operate like a real business. Rafay Systems landing on Deloitte's 2026 Technology Fast 500 for a third straight year is another signal that the AI infrastructure scramble has moved well beyond simply finding chips. Somebody has to turn all that expensive compute into services customers can provision, use, measure and...

Continue Reading
Holland America Puts 2028 Alaska Demand on Display

Updated Category News Views 123

Alaska’s interior is where a cruise brochure either earns its keep or gets exposed. Holland America Line is opening bookings for 2028 Alaska Cruisetours nearly two years ahead, tying a coast-and-land product to the reimagined Oosterdam’s Alaska debut. That is not merely another itinerary release. It is a fairly deliberate attempt to sell a bigger, longer and...

Continue Reading
Sungrow Puts Storage Safety and Deployment on Display

Updated Category News Views 177

Fire-test footage is not usually the thing that grabs a room in Las Vegas, but Sungrow made it the centerpiece at RE+ 2026 for a reason. Energy storage has no shortage of glossy promises; what it needs is proof that equipment can handle the ugly stuff. Sungrow used the show to pitch a broader North American lineup, yet the PowerTitan 3.0 battery system and its large-scale...

Continue Reading
Automotive Laminates: Small Market, Real EV Leverage

Updated Category News Views 183

Cabin trim has become a surprisingly serious battleground, and that is the whole point of this automotive laminates story. Nobody buys a vehicle because somebody bragged about a multilayer film behind the door panel. Yet the materials under the fingertips, beneath the carpet, and around the dashboard increasingly decide whether an interior feels cheap, quiet, durable, or...

Continue Reading
Mace Consult Bets on Sawaya for Americas Expansion

Updated Category News Views 93

Concrete, tunnel bores, and data-center campuses rarely wait politely for a leadership transition. Mace Consult has named Mario Sawaya president of its Americas business, and the hire reads less like ceremonial executive shuffling than a deliberate move toward the thickest part of the capital-spending map. Sawaya brings more than 20 years of experience leading...

Continue Reading

Top 5 Most Recently Viewed Articles

10 Strategies for Real Estate Investors: Stay Ahead of Risks

Updated Category Real Estate Views 1172

Introduction: 10 Easy Tips for Smart Property Investors Are you inve­sting in real estate? Pre­pare ahead to avoid costly surprises down the­ road. Imagine buying a property only to learn about hidde­n issues later. Wouldn't it be be­tter to anticipate risks early on? In re­al estate, staying informed can make­ or break your success. That's why this guide will help...

Continue Reading
Investors Show Strong Interest in Nike Options Trading Activity

Updated Category News Views 181

Market Whales and Their Recent Bets on NKE Options Recently, there has been significant interest among prominent investors in Nike, showcasing a bullish attitude toward the stock. Analyzing Options Trades for Nike (NYSE: NKE) Upon reviewing Nike's options history, we've identified multiple trades that reflect a notable trend. A clear majority of 50% of these trades have...

Continue Reading
AdTech Holding Celebrates Prestigious Workplace Certification

Updated Category News Views 176

AdTech Holding Achieves Recognition for Workplace Excellence AdTech Holding has recently earned the esteemed Great Place To Work® Certification™ for the third consecutive year. This notable achievement reflects the genuine feedback from employees concerning the workplace culture, trust, and the opportunities for professional growth that the company fosters. A...

Continue Reading
Innovative Truck Bed Design Revolutionizes Hauling for Drivers

Updated Category News Views 285

Enhancing Pickup Truck Hauling with Innovative Designs Many truck owners often face the challenge of maximizing their vehicle's hauling capabilities, especially when it comes to transporting large loads. One inventive solution that rises to this challenge is the BRIELLA TRUCK BEDS. This innovative design allows pickup trucks to convert effectively into flatbed trucks,...

Continue Reading
Investigation on Behalf of Long-Term Shareholders of Multiple Companies

Updated Category News Views 131

Investigation Into Geron Corporation and Other Companies Johnson Fistel, PLLP is conducting an investigation into potential violations of both federal and state securities laws. This inquiry focuses on the actions of certain officers and directors within Geron Corporation, Viatris Inc., Everus Construction Group, Inc., and SoundHound AI, Inc. Shareholders, particularly...

Continue Reading